Affiliations
AffiliationsItem in Clipboard
Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provisionEdinah Mudimu et al. PLoS One. 2020.
. 2020 Dec 31;15(12):e0244761. doi: 10.1371/journal.pone.0244761. eCollection 2020. AffiliationsItem in Clipboard
AbstractBackground: Pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV and has the potential to significantly impact the HIV epidemic. Given limited resources for HIV prevention, identifying PrEP provision strategies that maximize impact is critical.
Methods: We used a stochastic individual-based network model to evaluate the direct (infections prevented among PrEP users) and indirect (infections prevented among non-PrEP users as a result of PrEP) benefits of PrEP, the person-years of PrEP required to prevent one HIV infection, and the community-level impact of providing PrEP to populations defined by gender and age in western Kenya and South Africa. We examined sensitivity of results to scale-up of antiretroviral therapy (ART) and voluntary medical male circumcision (VMMC) by comparing two scenarios: maintaining current coverage ("status quo") and rapid scale-up to meet programmatic targets ("fast-track").
Results: The community-level impact of PrEP was greatest among women aged 15-24 due to high incidence, while PrEP use among men aged 15-24 yielded the highest proportion of indirect infections prevented in the community. These indirect infections prevented continue to increase over time (western Kenya: 0.4-5.5 (status quo); 0.4-4.9 (fast-track); South Africa: 0.5-1.8 (status quo); 0.5-3.0 (fast-track)) relative to direct infections prevented among PrEP users. The number of person-years of PrEP needed to prevent one HIV infection was lower (59 western Kenya and 69 in South Africa in the status quo scenario; 201 western Kenya and 87 in South Africa in the fast-track scenario) when PrEP was provided only to women compared with only to men over time horizons of up to 5 years, as the indirect benefits of providing PrEP to men accrue in later years.
Conclusions: Providing PrEP to women aged 15-24 prevents the greatest number of HIV infections per person-year of PrEP, but PrEP provision for young men also provides indirect benefits to women and to the community overall. This finding supports existing policies that prioritize PrEP use for young women, while also illuminating the community-level benefits of PrEP availability for men when resources permit.
Conflict of interest statementI have read the journal’s policy and one of the authors of this manuscript has the following competing interests: KK is employed by a commercial company: Avenir Health. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products to declare.
FiguresFig 1. Direct prevention and total averted…
Fig 1. Direct prevention and total averted infections compared to status quo and fast-track baseline…
Fig 1. Direct prevention and total averted infections compared to status quo and fast-track baseline scenarios in South Africa and a status quo baseline scenario in Kenya.Fig 2. Indirect-to-direct ratio of infections averted…
Fig 2. Indirect-to-direct ratio of infections averted in South Africa and Kenya.
Scenarios show results…
Fig 2. Indirect-to-direct ratio of infections averted in South Africa and Kenya.Scenarios show results from PrEP provision by age and gender.
Fig 3. Number of person-years of PrEP…
Fig 3. Number of person-years of PrEP needed to prevent one HIV infection by country,…
Fig 3. Number of person-years of PrEP needed to prevent one HIV infection by country, baseline scenario, and PrEP provision strategy. Similar articlesGrant H, Gomez GB, Kripke K, Barnabas RV, Watts C, Medley GF, Mukandavire Z. Grant H, et al. Sex Transm Dis. 2020 Nov;47(11):767-777. doi: 10.1097/OLQ.0000000000001253. Sex Transm Dis. 2020. PMID: 33044426
Koss CA, Havlir DV, Ayieko J, Kwarisiima D, Kabami J, Chamie G, Atukunda M, Mwinike Y, Mwangwa F, Owaraganise A, Peng J, Olilo W, Snyman K, Awuonda B, Clark TD, Black D, Nugent J, Brown LB, Marquez C, Okochi H, Zhang K, Camlin CS, Jain V, Gandhi M, Cohen CR, Bukusi EA, Charlebois ED, Petersen ML, Kamya MR, Balzer LB. Koss CA, et al. PLoS Med. 2021 Feb 9;18(2):e1003492. doi: 10.1371/journal.pmed.1003492. eCollection 2021 Feb. PLoS Med. 2021. PMID: 33561143 Free PMC article.
van Vliet MM, Hendrickson C, Nichols BE, Boucher CA, Peters RP, van de Vijver DA. van Vliet MM, et al. J Int AIDS Soc. 2019 Dec;22(12):e25427. doi: 10.1002/jia2.25427. J Int AIDS Soc. 2019. PMID: 31855323 Free PMC article.
Verguet S, Stalcup M, Walsh JA. Verguet S, et al. Sex Transm Infect. 2013 Dec;89(8):628-34. doi: 10.1136/sextrans-2012-050891. Epub 2013 Aug 2. Sex Transm Infect. 2013. PMID: 23912819 Review.
Irungu EM, Baeten JM. Irungu EM, et al. Nat Med. 2020 May;26(5):655-664. doi: 10.1038/s41591-020-0872-x. Epub 2020 May 11. Nat Med. 2020. PMID: 32405065 Review.
Bonner CP, Browne FA, Carney T, Shangase N, Ndirangu JW, Myers B, Wechsberg WM. Bonner CP, et al. S Afr Med J. 2022 Apr 29;112(5):341-346. S Afr Med J. 2022. PMID: 35587247 Free PMC article.
Kaftan D, Sharma M, Resar D, Milali M, Mudimu E, Wu L, Arrouzet C, Platais I, Kim HY, Jenkins S, Bershteyn A. Kaftan D, et al. J Int AIDS Soc. 2025 Feb;28(2):e26427. doi: 10.1002/jia2.26427. J Int AIDS Soc. 2025. PMID: 39995017 Free PMC article.
Phillips AN, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily MC, Martin-Hughes R, Johnson LF, Mukandavire Z, Jamieson L, Meyer-Rath G, Hallett TB, Ten Brink D, Kelly SL, Nichols BE, Bendavid E, Mudimu E, Taramusi I, Smith J, Dalal S, Baggaley R, Crowley S, Terris-Prestholt F, Godfrey-Faussett P, Mukui I, Jahn A, Case KK, Havlir D, Petersen M, Kamya M, Koss CA, Balzer LB, Apollo T, Chidarikire T, Mellors JW, Parikh UM, Godfrey C, Cambiano V; HIV Modelling Consortium. Phillips AN, et al. Lancet HIV. 2022 May;9(5):e353-e362. doi: 10.1016/S2352-3018(22)00029-7. Lancet HIV. 2022. PMID: 35489378 Free PMC article.
Stover J, Kelly SL, Mudimu E, Green D, Smith T, Taramusi I, Bansi-Matharu L, Martin-Hughes R, Phillips AN, Bershteyn A. Stover J, et al. PLoS One. 2021 Dec 23;16(12):e0260820. doi: 10.1371/journal.pone.0260820. eCollection 2021. PLoS One. 2021. PMID: 34941876 Free PMC article.
Wittenauer R, Wu L, Cox S, Pfau B, Sharma M. Wittenauer R, et al. BMJ Glob Health. 2025 Jan 11;10(1):e015835. doi: 10.1136/bmjgh-2024-015835. BMJ Glob Health. 2025. PMID: 39800385 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3